SynapDx gets $6M boost to conduct autism test study

12/12/2012 | MedCityNews.com

SynapDx has obtained $6 million in financing, which it aims to use to support pivotal trials of a blood assay for diagnosing autism spectrum disorders in children as young as 36 months. The company plans to launch a study next year to evaluate the use of the test in validating performance attributes in 600 children who are at risk for ASD.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL